Please Note:

ReGen Therapeutics Limited was formerly a pharmaceutical company but sold that business many years ago. It is now a UK investment holding company and has no current involvement in pharmaceuticals, cancer research or drug development of any kind.

ReGen Therapeutics Limited
is merging with Futurum Group

ReGen Therapeutics was once a pharmaceutical development company. That chapter closed several years ago. This page tells you what has happened since and where things are heading.

About ReGen Therapeutics Limited

ReGen Therapeutics Limited (Company Registration No. 07476879) was originally a pharmaceutical development company but stopped research activity and the generation of revenue from licensing arrangements of it’s product Colostrinin several years ago.

Since then, shareholders have retained their holdings in the company while its directors, Timothy Shilton and Norman Lott, have been actively seeking the right opportunity to generate real value for those shareholders. That search led them to Futurum Group. To avoid any confusion with other businesses of a similar name, we want to be clear that ReGen Therapeutics Limited has no current involvement in pharmaceuticals, cancer research, drug development or medical treatments of any kind.

About Futurum Group

Futurum Group is a children's media and entertainment company already well on its way to success, with a portfolio of independently valued TV animation IPs, signed broadcaster contracts across 120+ countries with names including NBC Universal, Cartoonito and Netflix, and a clear pathway to a public listing on AIM or the London Stock Exchange later in 2026.

The merger brings together Futurum's momentum and IP with the capital raised through the ReGen Rights Issue, accelerating the machine and giving existing ReGen shareholders a meaningful stake in something with real global potential. Over 1,500 shareholders and external investors are already engaged in the merger process and the opportunity to invest in the merged company pre-IPO on generous terms.

Visit the merger portal →

ReGen Therapeutics Limited  ·  Registered in England & Wales. Registration No. 07476879  ·  info@regentherapeutics.uk
ReGen Therapeutics Limited is not affiliated with any pharmaceutical, biotechnology or medical research business.